专利信息

Translation Company

首页 1 2 尾页共 14 条记录, 当前第1/2页。

专利标题：IRINOTECAN FOR TREATMENT OF CANCER

专利标题：METHODS FOR THE TREATMENT OF CANCER WITH IRINOTECAN BASED ON CYP3A5

专利标题：METHODS FOR TREATMENT OF CANCER WITH IRINOTECAN BASED ON MDR1

专利标题：METHODS FOR TREATMENT OF CANCER USING IRINOTECAN BASED ON UGT1A1

专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER BASED ON MDR1

The present invention relates to the use of irinotecan or a derivative thereof for the preparation of a pharmaceutical composition for treating colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution comprised by said polynucleotide results in...

专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER BASED ON CYP3A5

The present invention relates to the use of irinotecan or a derivative thereof for the preparation of a pharmaceutical composition for treating cancer, especially, colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution comprised by said polyn...

专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER

The present invention relates to the use of irinotecan or a derivative thereof for the preparation of a pharmaceutical composition for treating colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a first, a second, a third, and/or a fourth variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution c...

专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER BASED ON UGT1A1

The present invention relates to the use of irinotecan or a derivative thereof for the preparation of a pharmaceutical composition for treating colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a varient allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution comprised by said polynucleotide results in...

专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER BASED ON MRP1

The present invention relates to the use of irinotecan or derivative thereof for the preparation of a pharmaceutical composition for treating cancer, especially, colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution comprised by said polynuc...

专利标题：IRINOTECAN FOR TREATMENT OF CANCER

The present invention relates to the use of irinotecan or a derivative there of for the preparation of a pharmaceutical composition for treating colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a first, a second, a third, and/or a fourth variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution ...

当前查询条件: [专利权人] 包含 'EPIDAUROS BIOTECHNOLOGIE AG [DE]' AND [药品] 包含 'Irinotecan '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. EP1438050A2	2004/7/21	EP20020764763	2002/7/23
专利标题：IRINOTECAN FOR TREATMENT OF CANCER 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE];

2. EP1408975A2	2004/4/21	EP20020767255	2002/7/23
专利标题：METHODS FOR THE TREATMENT OF CANCER WITH IRINOTECAN BASED ON CYP3A5 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE];

3. EP1408972A2	2004/4/21	EP20020764764	2002/7/23
专利标题：METHODS FOR TREATMENT OF CANCER WITH IRINOTECAN BASED ON MDR1 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE];

4. EP1408974A2	2004/4/21	EP20020764762	2002/7/23
专利标题：METHODS FOR TREATMENT OF CANCER USING IRINOTECAN BASED ON UGT1A1 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE];

5. WO03013535A2	2003/2/20	WO2002EP08220	2002/7/23
专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER BASED ON MDR1 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE];HEINRICH GUENTHER [DE];KERB REINHOLD [DE]; The present invention relates to the use of irinotecan or a derivative thereof for the preparation of a pharmaceutical composition for treating colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution comprised by said polynucleotide results in...

6. WO03013534A2	2003/2/20	WO2002EP08219	2002/7/23
专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER BASED ON CYP3A5 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE];HEINRICH GUENTHER [DE];KERB REINHOLD [DE]; The present invention relates to the use of irinotecan or a derivative thereof for the preparation of a pharmaceutical composition for treating cancer, especially, colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution comprised by said polyn...

7. WO03013537A2	2003/2/20	WO2002EP08218	2002/7/23
专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE];HEINRICH GUENTHER [DE];KERB REINHOLD [DE]; The present invention relates to the use of irinotecan or a derivative thereof for the preparation of a pharmaceutical composition for treating colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a first, a second, a third, and/or a fourth variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution c...

8. WO03013536A2	2003/2/20	WO2002EP08217	2002/7/23
专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER BASED ON UGT1A1 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE];HEINRICH GUENTHER [DE];KERB REINHOLD [DE]; The present invention relates to the use of irinotecan or a derivative thereof for the preparation of a pharmaceutical composition for treating colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a varient allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution comprised by said polynucleotide results in...

9. WO03013533A2	2003/2/20	WO2002EP08200	2002/7/23
专利标题：MEANS AND METHODS FOR IMPROVED TREATMENT OF CANCER BASED ON MRP1 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE];HEINRICH GUENTHER [DE];KERB REINHOLD [DE]; The present invention relates to the use of irinotecan or derivative thereof for the preparation of a pharmaceutical composition for treating cancer, especially, colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution comprised by said polynuc...

10. CA2454648A1	2003/2/20	CA20022454648	2002/7/23
专利标题：IRINOTECAN FOR TREATMENT OF CANCER 专利权人：EPIDAUROS BIOTECHNOLOGIE AG [DE]; The present invention relates to the use of irinotecan or a derivative there of for the preparation of a pharmaceutical composition for treating colorectal cancer, cervical cancer, gastric cancer, lung cancer, malignant glioma, ovarian cancer, and pancreatic cancer in a patient having a genotype with a first, a second, a third, and/or a fourth variant allele which comprises a polynucleotide in accordance with the present invention. Preferably, a nucleotide deletion, addition and/or substitution ...

下载范围

下载内容